Skip to content

Inventory reserve at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$40.75K
Ceco Environmental logo
Ceco EnvironmentalCECO
$1.08M+1,076%
Fox Factory Holding Corp. logo
Fox Factory Holding Corp.FOXF
$512K-70.4%
CSW Industrials, Inc. logo
CSW Industrials, Inc.CSW
$229K-74.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0+100%
Glaukos logo
GlaukosGKOS
$334.75K+102%

Other financials

Income statement

See full
Revenue$223.4M-26.1%
Gross profit$63.0M-17.6%
Operating income$7.1M-73.9%
Net income$2.0M-88.1%
EPS (diluted)-$0.09-550%

Balance sheet

See full
Cash & equivalents$202.0M-42.2%
Total debt$763.2M+12.4%
Total equity-$214.4M-119%
Total assets$1.5B+3.5%

Cash flow

See full
Operating cash flow-$29.4M-125%
CapEx$7.5M+219%
Free cash flow-$36.9M-140%

Valuation

See full
Market cap$1.18B+4.8%
Enterprise value$1.74B+19.6%
P/S-0.1×

Profitability

See full
Gross margin23.7%-6.3pp
Operating margin-4.1%-1.8pp
Net margin-5.6%-2.4pp
FCF margin4.8%-3.3pp

Returns & leverage

See full
Return on equity-64.1%
Debt / equity10.5×+7.4×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by Array Technologies, Inc. in its filing.

Tagged under the XBRL concept arry:InventoryReserveAdjustmentsExcludingWriteoff.

The official record: Array Technologies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Array Technologies, Inc.'s inventory reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Array Technologies, Inc.'s inventory reserve?
Array Technologies, Inc. (ARRY) reported inventory reserve of -$526K in Q1 2026.
How has Array Technologies, Inc.'s inventory reserve changed year-over-year?
Array Technologies, Inc.'s inventory reserve decreased by 162.7% year-over-year, from $839K to -$526K.
What does inventory reserve mean?
This represents the periodic adjustments made to inventory valuation accounts to account for potential obsolescence, slow-moving stock, or market value declines. It provides insight into the company's ability to manage inventory turnover and the risk of holding stagnant product assets.